Global Blood-grouping Reagents Market 2025-2029

Blood-Grouping Reagents Market 2025-2029

The blood-grouping reagents market is forecasted to grow by USD 611.8 million during 2024-2029, accelerating at a CAGR of 8.8% during the forecast period. The report on the blood-grouping reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic disorders, rise in blood donations, and growing number of hospitals and blood banks.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's blood-grouping reagents market is segmented as below:

By End-user

• Hospitals and blood banks
• Clinical laboratories
• Academic and research institutes

By Technique

• PCR-based and microarray techniques
• Assay-based techniques
• Massively parallel sequencing techniques
• Serology

By Product

• Anti-sera reagents
• Red blood cell reagents
• Blood bank saline
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advancements in diagnostic devices as one of the prime reasons driving the blood-grouping reagents market growth during the next few years. Also, growing adoption of multiplexing assays and integration of automation and high-throughput platforms in blood grouping will lead to sizable demand in the market.

The report on the blood-grouping reagents market covers the following areas:

• Blood-Grouping Reagents Market sizing
• Blood-Grouping Reagents Market forecast
• Blood-Grouping Reagents Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood-grouping reagents market vendors that include AliveDx, Arena Bio Scien, ARKRAY Inc., Atlas Medical GmbH, BAG Health Care GmbH, Bio RAD Laboratories Inc., Calibre Scientific Inc., Danaher Corp., DIAGAST SAS, Fortress Diagnostics, Grifols SA, Merck KGaA, Novacyt SA, Paragon Care Group, QuidelOrtho Corp., Rapid Labs Ltd., Thermo Fisher Scientific Inc., Torax Biosciences Ltd., and Tulip Diagnostics Pvt. Ltd.. Also, the blood-grouping reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.